2024/09/20 13:00:22 | |
---|---|
Price | |
44.065 EUR | |
Difference | -0.42% (-0.19) |
ISIN | US1101221083 |
Symbol | BMY |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 89,062 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 43.97 EUR (255) |
Ask (Ask size) | 44.165 EUR (255) |
Open | 43.90 EUR |
High | 44.065 EUR |
Low | 43.90 EUR |
Close (prev. day) | 44.25 EUR |
VWAP | 45.141622 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/20 13:00:22 | |
---|---|
Price | |
44.065 EUR | |
Difference | -0.42% (-0.19) |
ISIN | US1101221083 |
Symbol | BMY |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 89,062 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 43.97 EUR (255) |
Ask (Ask size) | 44.165 EUR (255) |
Open | 43.90 EUR |
High | 44.065 EUR |
Low | 43.90 EUR |
Close (prev. day) | 44.25 EUR |
VWAP | 45.141622 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -7.23% | -19.10% | -14.67% |
Perf (abs.) | -3.45 | -10.45 | -7.61 |
Beta | 0.19 | 0.34 | 0.29 |
Volatility | 29.76 | 27.30 | 23.16 |
Ø price 5 days | Ø volume 5 days (pcs.) | 44.403 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 44.210 EUR (15) |
Ø price 100 days | Ø volume 100 days (pcs.) | 41.090 EUR (17) |
Ø price 250 days | Ø volume 250 days (pcs.) | 45.043 EUR (18) |
YTD High | date | 50.200 EUR (2024/03/28) |
YTD Low | date | 36.415 EUR (2024/07/05) |
52 Weeks High | date | 55.900 EUR (2023/09/26) |
52 Weeks Low | date | 36.415 EUR (2024/07/05) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/09/20 | 10:35 | 44.035 EUR | 0.05 | 16 |
Vienna Stock Exchange | 2024/09/20 | 13:00 | 44.065 EUR | 0.00 | 3 |
Tradegate | 2024/09/20 | 12:23 | 44.08 EUR | 0.05 | 17 |
Stuttgart | 2024/09/20 | 13:00 | 44.185 EUR | 0.01 | 3 |
SIX Swiss Exchange | 2019/06/28 | 17:35 | 44.39 CHF | 0.00 | 1 |
SIX Swiss Exchange | 2019/07/03 | 05:55 | 45.30 USD | 0.00 | 1 |
NYSE | 2024/09/19 | 22:00 | 49.02 USD | 435.18 | 78,629 |
Munich | 2024/09/20 | 08:01 | 44.05 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2024/09/20 | 10:00 | 49.1525 USD | 0.00 | 1 |
Hanover | 2024/09/20 | 08:01 | 43.81 EUR | 0.00 | 1 |
Hamburg | 2024/09/20 | 08:01 | 43.805 EUR | 0.00 | 1 |
Frankfurt | 2024/09/20 | 13:15 | 44.00 EUR | 0.00 | 3 |
Euronext Milan MTF Trading After Hours | 2024/07/29 | 18:00 | 46.63 EUR | 0.00 | 2 |
Euronext Milan MTF Global Equity Market | 2024/09/19 | 17:44 | 44.30 EUR | 0.00 | 1 |
Duesseldorf | 2024/09/20 | 12:30 | 43.86 EUR | 0.00 | 4 |
Berlin | 2024/09/20 | 08:01 | 43.805 EUR | 0.00 | 1 |
BRISTOL MYERS SQUIBB CO. |
- - |
Route 206 & Province Line Road - 08543 Princeton |
Telefon: +1-609-252-4621 |
Fax: + |
E-mail: - |
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ. |
Deepak Bhatt | Member of Board of Directors |
Julia Haller | Member of Board of Directors |
Karen Vousden | Member of Board of Directors |
Manuel Hidalgo Medina | Member of Board of Directors |
Derica Rice | Member of Board of Directors |
Michael McMullen | Member of Board of Directors |
Paula Price | Member of Board of Directors |
Peter Arduini | Member of Board of Directors |
Phyllis Yale | Member of Board of Directors |
Theodore Samuels | Member of Board of Directors |
Chris Boerner | Chairman of Managing Board |
Adam Lenkowsky | Member of Executive Committee |
Amanda Poole | Member of Executive Committee |
Cari Gallman | Member of Executive Committee |
David Elkins | Member of Executive Committee |
Greg Meyers | Member of Executive Committee |
Karin Shanahan | Member of Executive Committee |
Kim Jablonski | Member of Executive Committee |
Lynelle B. Hoch | Member of Executive Committee |
Pamela Fisher | Member of Executive Committee |
Peter S. Paine III | Member of Executive Committee |
Robert Plenge | Member of Executive Committee |
Samit Hirawat | Member of Executive Committee |
Sandra Leung | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer